Our mission is to find treatments and a cure for the rare cancer, epithelioid hemangioendothelioma (EHE), by advancing research and driving collaboration among patients, researchers, and clinicians. We are bringing the best minds in research and industry to EHE, accelerating the pathway from discovery to treatment, and including the patient’s voice at every step. Our pledge to the EHE community is an unwavering commitment to pioneering research, innovative funding, and groundbreaking drug development for EHE. Momentum is happening in EHE research and therapeutic development. The EHE Foundation is leading the charge toward a world where EHE is easily diagnosed and treated–better yet, cured!